Tc-99m MIBI Uptake and Its Relation to the Proliferative Potential of Brain Tumors

Clinical Nuclear Medicine

Volumn 28, Issue 1, 2003, Pages 29-33

  Ak, Ilknur ^a   Gülbaş, Zafer ^a   Altinel, Faruk ^a   Vardareli, Erkan ^b  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Clinics of Psychiatry   (Turkey)

Author keywords

Brain Tumor; DNA Analysis; Tc 99m MIBI

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; DNA; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; ARTICLE; BRAIN TUMOR; CANCER GRADING; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; COLLIMATOR; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING; DIPLOIDY; DNA CONTENT; DNA DETERMINATION; DRUG UPTAKE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ASTROCYTOMA; CELL DIVISION; CHEMISTRY; GENETICS; INTERPHASE; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; SCINTISCANNING;

AGED; ANEUPLOIDY; ASTROCYTOMA; BRAIN NEOPLASMS; CELL DIVISION; CHILD, PRESCHOOL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; INTERPHASE; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; S PHASE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0037209296     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200301000-00007     Document Type: Article

References (28)

1. Wackers F, Berman D, Maddahi J, et al: Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 30:301, 1989.
2. Mousa S, Williams S, Sands H: Characterization of in vivo chemistry of cations in the heart. J Nucl Med 28:1351, 1987.
3. Piwnika-Worms D, Kronauge J, Holman B: Hexakis (carbomethoxyisopropylisonitrile) technetium (I), a new myocardial perfusion imaging agent: binding characteristics in cultured chick heart cells. J Nucl Med 29:55, 1988.
4. Delmon-Moingeon L, Piwnica-Worms D, Van den Abbeele A, et al: Uptake of cation hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell line in vitro. Cancer Res 50:2198, 1990.
5. Pauwels E, McCready V, Stoot J, et al: The mechanism of accumulation of tumor-localising radiopharmaceuticals. Eur J Nucl Med 25:277, 1998.
6. Chiu M, Kronauge J, Piwnika-Worms D: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)-technetium (I) in cultured mouse fibroblast. J Nucl Med 31:1646, 1990.
7. Crane P, Laliberte L, Heminway S, et al: Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 20:20, 1993.
8. Carvalho P, Chiu M, Kronauge J, et al: Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 33:1516, 1992.
9. Piwnica-Worms D, Kronauge J, Chiu M: Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 82:1826, 1990.
10. Piwnika-Worms D: Functional imaging of mutidrug-resistant P-glycoprotein with an organo-technetium complex. Cancer Res 53:1993.
11. Chen L, Summerhayes I, Nadakavukaren K, et al: Mitochondria in tumor cells: effect of cytoskeleton on distribution and as targets for selective killing. In: Feramisco J, Ozanne B, Stiles C, eds. Cancer Cells: The Transformed Phenotype. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1984, p 75.
12. Muller S, Guth-Tougelidis B, Creutzig H: Imaging of malignant tumors with Tc-99m-MIBI SPECT [Abstract]. J Nucl Med 28: 562, 1987.
13. Palmedo H, Biersack H, Lastoria S, et al: Scintimammography with technetium 99m-methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med 25:375, 1998.
14. Foldes I, Levay A, Stotz G: Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 20:330, 1993.
15. Soderlund V, Jonsson C, Bauer H, et al: Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas. J Nucl Med 38:682, 1997.
16. Adams B, Fataar A, Nizami M: Technetium-99m-sestamibi uptake in myeloma. J Nucl Med 37:1001, 1996.
17. O'Tuama L, Treves S, Larar J, et al: Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 34:1045, 1993.
18. Tomura N, Hirano H, Watanabe O, et al: Preliminary results with technetium-99m MIBI SPECT imaging in patients with brain tumors: correlation with histological and neuroradiological diagnoses and therapeutic response. Comput Med Imaging Graph 21:293, 1997.
19. Yokogami K, Kawano H, Moriyama T, et al: Application of SPECT using technetium-99m sestamibi in brain tumors and comparison with expression of the MDR-1 gene: Is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPECT. Eur J Nucl Med 25:401, 1998.
20. Nishiyama Y, Yamamoto Y, Fukunaga K, et al: Comparison of 99Tcm-MIBI with 201TI chloride SPET in patients with malignant brain tumors. Nucl Med Commun 22:631, 2001.
21. Soler C, Beauchesne P, Maatougui K, et al: Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 25:1649, 1998.
22. Ambrus E, Kuncz A, Janoki G, et al: Evaluation of the nature of brain tumors using methods of nuclear medicine. Orv Hetil 140:1979, 1999.
23. Alkiza K, Adan B, Garibi J, et al: The evaluation of cell proliferation in gliomas. Rev Neurol 30:141, 2000.
24. Garcia R, Bueno A, Castanon S, et al: Study of the DNA content by flow cytometry and proliferation in 281 brain tumors. Oncology 54:112, 1997.
25. Chiang M, Chang C, Chen M, et al: Nuclear multiparameter flow cytometric DNA analysis of human brain tumors: correlation of DNA content with tumor histology and clinical behavior. Surg Neurol 50:65, 1998.
26. Gasinska A, Krzyszkowski T, Skolyszewski J, et al: Flow cytometric analysis of DNA ploidy and proliferative potential in brain tumors. Folia Histochem Cytobiol 36:133, 1998.
27. Lahiri M, Sehgal S, Kak V, et al: Flowcytometric and histopathological correlation of primary intracranial neoplasms. Neurol India 49:124, 2001.
28. Vindelov L, Christensen I, Nissen N: Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Cytometry 3:332, 1983.